Sarepta Therapeutics Inc.

09/30/2024 | Press release | Distributed by Public on 09/30/2024 07:21

Sarepta Therapeutics anuncia a los destinatarios de las subvenciones de 2024 para LGMD; el programa apoya las pruebas genéticas tempranas y la concientización

Sarepta Therapeutics Inc. published this content on September 30, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 30, 2024 at 13:21 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]